Sommaire

Numéro précédent | Numéro suivant

• • ·Cancer survivors: still room for improvement

    Page :609

     
• • ·Adjuvant bisphosphonates for early-stage breast cancer

    Page :610-611

    Adam Brufsky

     
• • ·Survival benefit in hepatocellular carcinoma: when an innovative transplant strategy might benefit oncology

    Page :611-612

    Georgios C Sotiropoulos

     
• • ·A new approach to cervical screening

    Page :612-613

    Chris JLM Meijer, Johannes Berkhof, Peter JF Snijders

     
• • ·Combination therapy in metastatic renal cell carcinoma

    Page :613-614

    Daniel YC Heng

     
• • ·Oesophageal cancer: who needs neoadjuvant therapy?

    Page :615-616

    Thomas N Walsh

     
• • ·Optimising the lymphoma response criteria in the era of targeted therapy

    Page :616-617

    Anas Younes, Anton Hagenbeek, Bertrand Coiffier

     
• • ·Multiple myeloma and the road to personalised medicine

    Page :617-619

    Stephen J Russell, S Vincent Rajkumar

     
• • ·Oncology perspectives: a call for essays

    Page :620

    Emma Grainger

    
• • ·Stenting as a bridge to surgery for colorectal cancer

    Page :621

    Valerie Bridoux, Babak Kianifard, Grégoire Moutel, Christian Herve, Jean-Jacques Tuech

     
• • ·Stenting as a bridge to surgery for colorectal cancer – Authors’ reply

    Page :621-622

    Jeanin E van Hooft, Willem A Bemelman, Marcel G Dijkgraaf, Paul Fockens

    
• • ·Genetics of lung cancer susceptibility and COPD

    Page :622-623

    RP Young, RJ Hopkins, C Etzel, R El-Zein

     
• • ·Carcinogenicity of radiofrequency electromagnetic fields

    Page :624-626

    Robert Baan, Yann Grosse, Béatrice Lauby-Secretan, Fatiha El Ghissassi, Véronique Bouvard, Lamia Benbrahim-Tallaa, Neela Guha, Farhad Islami, Laurent Galichet, Kurt Straif, on behalf of the WHO International Agency for Research on Cancer Monograph Working Group

     
• • ·16th congress of the European Hematology Association

    Page :626

    Audrey Ceschia

    Plan Plan  
• • ·2011 American Society of Clinical Oncology Annual Meeting

    Page :627-628

    Laura Benham

    Plan Plan
• • ·Breast Cancer Breakthroughs: Living Longer

    Page :629

    Helen Budd

     
• • ·Nutrition and the Cancer Patient

    Page :629-630

    Marina Mourtzakis

     
• • ·The Clink of Ice (Le Bruit des Glaçons)

    Page :630

    Talha Burki

     
• • ·Adjuvant endocrine therapy plus zoledronic acid in premenopausal women with early-stage breast cancer: 62-month follow-up from the ABCSG-12 randomised trial

    Page :631-641

    Michael Gnant, Brigitte Mlineritsch, Herbert Stoeger, Gero Luschin-Ebengreuth, Dietmar Heck, Christian Menzel, Raimund Jakesz, Michael Seifert, Michael Hubalek, Gunda Pristauz, Thomas Bauernhofer, Holger Eidtmann, Wolfgang Eiermann, Guenther Steger, Werner Kwasny, Peter Dubsky, Gerhard Hochreiner, Ernst-Pius Forsthuber, Christian Fesl, Richard Greil, on behalf of the Austrian Breast and Colorectal Cancer Study Group, Vienna, Austria

    Résumé Résumé Plan Plan   
• • ·Intermittent versus continuous oxaliplatin and fluoropyrimidine combination chemotherapy for first-line treatment of advanced colorectal cancer: results of the randomised phase 3 MRC COIN trial

    Page :642-653

    Richard A Adams, Angela M Meade, Matthew T Seymour, Richard H Wilson, Ayman Madi, David Fisher, Sarah L Kenny, Edward Kay, Elizabeth Hodgkinson, Malcolm Pope, Penny Rogers, Harpreet Wasan, Stephen Falk, Simon Gollins, Tamas Hickish, Eric M Bessell, David Propper, M John Kennedy, Richard Kaplan, Timothy S Maughan, on behalf of the MRC COIN Trial Investigators

    Résumé Résumé Plan Plan   
• • ·Barcelona Clinic Liver Cancer staging and transplant survival benefit for patients with hepatocellular carcinoma: a multicentre, cohort study

    Page :654-662

    Alessandro Vitale, Rafael Ramirez Morales, Giacomo Zanus, Fabio Farinati, Patrizia Burra, Paolo Angeli, Anna Chiara Frigo, Paolo Del Poggio, Gianludovico Rapaccini, Maria Anna Di Nolfo, Luisa Benvegnù, Marco Zoli, Franco Borzio, Edoardo Giovanni Giannini, Eugenio Caturelli, Maria Chiaramonte, Franco Trevisani, Umberto Cillo, on behalf of the Italian Liver Cancer group ‡

    Résumé Résumé Plan Plan   
• • ·Cervical cancer risk for women undergoing concurrent testing for human papillomavirus and cervical cytology: a population-based study in routine clinical practice

    Page :663-672

    Hormuzd A Katki, Walter K Kinney, Barbara Fetterman, Thomas Lorey, Nancy E Poitras, Li Cheung, Franklin Demuth, Mark Schiffman, Sholom Wacholder, Philip E Castle

    Résumé Résumé Plan Plan   
• • ·Temsirolimus and bevacizumab, or sunitinib, or interferon alfa and bevacizumab for patients with advanced renal cell carcinoma (TORAVA): a randomised phase 2 trial

    Page :673-680

    Sylvie Négrier, Gwenaëlle Gravis, David Pérol, Christine Chevreau, Rémy Delva, Jacques-Olivier Bay, Ellen Blanc, Céline Ferlay, Lionnel Geoffrois, Frédéric Rolland, Eric Legouffe, Emmanuel Sevin, Brigitte Laguerre, Bernard Escudier

    Résumé Résumé Plan Plan   
• • ·Survival after neoadjuvant chemotherapy or chemoradiotherapy for resectable oesophageal carcinoma: an updated meta-analysis

    Page :681-692

    Katrin M Sjoquist, Bryan H Burmeister, B Mark Smithers, John R Zalcberg, R John Simes, Andrew Barbour, Val Gebski, for the Australasian Gastro-Intestinal Trials Group

    Résumé Résumé Plan Plan   
• • ·The ribonucleotide reductase large subunit (RRM1) as a predictive factor in patients with cancer

    Page :693-702

    Lars Petter Jordheim, Pascal Sève, Olivier Trédan, Charles Dumontet

    Résumé Résumé Plan Plan  
• • ·International Cognition and Cancer Task Force recommendations to harmonise studies of cognitive function in patients with cancer

    Page :703-708

    Jeffrey S Wefel, Janette Vardy, Tim Ahles, Sanne B Schagen

    Résumé Résumé Plan Plan